Submission Details
| 510(k) Number | K172254 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 26, 2017 |
| Decision Date | October 23, 2017 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K172254 is an FDA 510(k) clearance for the Lyme B. burgdorferi (IgM) MarStripe Test, a Reagent, Borrelia Serological Reagent (Class II — Special Controls, product code LSR), submitted by Trinity Biotech (Buffalo, US). The FDA issued a Cleared decision on October 23, 2017, 89 days after receiving the submission on July 26, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K172254 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 26, 2017 |
| Decision Date | October 23, 2017 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LSR — Reagent, Borrelia Serological Reagent |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |